
zzso a zzso zzso zzso zzso zzso is in phase III clinical trial for the treatment of patients with zzso lung cancer and gastric cancer in zzso In this study, we determined the effect of zzso on the interaction of specific zzso compounds with zzso zzso zzso resistance protein 1 zzso zzso and breast cancer resistance protein zzso zzso Our results showed that zzso significantly enhanced the zzso of zzso or zzso zzso drugs in zzso zzso and zzso cells zzso zzso and in zzso zzso and zzso cells zzso zzso zzso In contrast, zzso did not alter the zzso of specific zzso in the parental cells and cells zzso zzso zzso significantly increased the zzso zzso of zzso 123 and zzso in the zzso resistance zzso zzso Furthermore, zzso significantly inhibited the zzso labeling of both zzso and zzso with zzso in a zzso zzso The zzso activity of both zzso and zzso was significantly increased by zzso However, zzso at a concentration that produced a reversal of zzso did not significantly alter the zzso or zzso protein or zzso expression levels or the zzso of zzso and zzso zzso zzso 1/2 zzso zzso zzso significantly enhanced the effect of zzso against the zzso zzso cancer cell zzso in nude zzso In conclusion, zzso reverses zzso and zzso zzso by zzso their transport function, but not by blocking the zzso or zzso zzso or zzso zzso or zzso zzso zzso may be useful in zzso zzso to other conventional zzso zzso 

